Key result
Female athletes reported more symptoms but had a lower prevalence of abnormal ECGs compared with male athletes.
Why the study?
Preparticipation examination findings among American athletes had not been sufficiently described across sex, participation level, and age.
Do preparticipation examination findings differ by sex, participation level, and age in American student athletes?
Cohort (n=2,954)
No
Do preparticipation examination findings differ by sex, participation level, and age in American student athletes?
In American student athletes, female, novice, and younger athletes report more symptoms, while male athletes have a higher prevalence of abnormal ECGs, though clinically important findings are comparable across all groups.
Answers are grounded in this paper and cite their sources.
Sex-specific differences in symptoms and ECGs among student athletes merit consideration during screening; observational data leaves open effects on outcomes and optimal protocols.
OBJECTIVE: To describe the preparticipation examination findings among American athletes by sex, participation level, and age. DESIGN: Hypothesis-generating retrospective cohort study. SETTING: Saint-Luke's Athletic Heart Center, Kansas City, Missouri. PARTICIPANTS: A total of 2954 student athletes. INTERVENTIONS: Athletes underwent preparticipation examination, which included history and physical, electrocardiogram, and 2-D transthoracic echocardiogram. MAIN OUTCOME MEASURES: Differences noted on screening preparticipation examination by sex, participation level, and age. RESULTS: Female athletes reported more symptoms than male athletes (odds ratio [OR] = 1.61; 95% confidence interval [CI], 1.32-1.97; P < 0.0001) but had lower prevalence of abnormal electrocardiogram (OR 0.52; CI, 0.39-0.68; P < 0.0001). College athletes reported fewer symptoms than novice athletes (OR 0.35; CI, 0.29-0.43; P < 0.0001) with no difference in the prevalence of abnormal electrocardiography (ECG) (OR 0.96; CI, 0.73-1.26; P = 0.78). Older athletes reported fewer symptoms than younger athletes (OR 0.61; CI, 0.52-0.71; P < 0.0001) with no difference in the prevalence of abnormal ECG (OR 1.00; CI, 0.81-1.23; P = 0.89). There were 43 athletes with clinically important findings with no difference in prevalence of these findings across sex, participation level, and age. CONCLUSIONS: Among this American cohort of athletes, male athletes reported fewer symptoms and had higher prevalence of abnormal ECG findings compared with female athletes. College and older athletes reported fewer symptoms and had no difference in prevalence of abnormal ECG findings compared with novice and younger athletes, respectively. Despite these differences between groups, the prevalence of clinically important findings was comparable among groups.
No takes yet. Share an insight, caveat, or question.
Willard et al. (2020) conducted a cohort in Student athletes (n=2,954). Female sex vs. Male sex was evaluated on Reported symptoms (OR 1.61, 95% CI 1.32-1.97, p=< 0.0001). Female athletes reported more symptoms but had a lower prevalence of abnormal ECGs compared with male athletes.
Synapse has enriched 10 related papers. Consider them for comparative context: